Noetik co-founders: CEO Ron Alfa (L) and CSO Jacob Rinaldi

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

Two for­mer lead­ers of Re­cur­sion Phar­ma­ceu­ti­cals have start­ed their own biotech start­up, hop­ing to bring a sim­i­lar da­ta-ob­sessed men­tal­i­ty to can­cer re­search.

The San Fran­cis­co …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.